1.Lanata, CF et al. (2013) Global causes of diarrheal disease mortality in children <5 years of age: a systematic review. PLoS One 8, e72788.
2.Mészner, Z et al. (2013) Rotavirus vaccination in central Europe. Journal of Pediatric Gastroenterology and Nutrition 56, 586–596.
3.Velazquez, FR et al. (2000) Serum antibody as a marker of protection against natural rotavirus infection and disease. Journal of Infectious Diseases 182, 1602–1609.
4.WHO Position paper (2013) Rotavirus vaccines. Weekly Epidemiology Record 88, 49–64.
5.Santos, VS et al. (2016) Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis. Infectious Diseases Poverty 5, 83.
7.Bok, K et al. (1999) Rotavirus laboratory network: results after one year of observation (In Spanish). Revista Argentina de Microbiologia 31, 1–12.
8.Bok, K et al. (2001) Surveillance of rotavirus in Argentina. Journal of Medical Virology 65, 190–198.
9.Garcia Martí, S et al. (2015) Cost effectiveness evaluation of a rotavirus vaccination program in Argentina. Vaccine 33, 5684–5690.
10.Brodersen, KH et al. (2015) Inferring causal impact using Bayesian structural time-series models. Annals of Applied Statistics 9, 247–274.
11.Abadie, A, Diamond, A and Hainmuller, J (2010) Synthetic control methods for comparative case studies: estimating the effect of California's tobacco control program. Journal of American Statistical Association 105, 493–505.
12.Abadie, A and Gardeazabal, J (2003) The economic costs of conflict: a case study of the Basque country. American Economic Review 93, 113–132.
13.George, EJ and McCulloch, RE (1997) Approaches for Bayesian variable selection. Statistica Sinica 7, 339–374.
14.do Carmo, GM et al. (2011) Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Medecine 8, e1001024.
15.Lanzieri, TM et al. (2010) Trends in hospitalizations from all-cause gastroenteritis in children younger than 5 years of age in Brazil before and after human rotavirus vaccine introduction, 1998–2007. Pediatric Infectious Diseases Journal 29, 673–675.
16.Molto, Y et al. (2011) Reduction of diarrhea-associated hospitalizations among children aged <5 years in Panama following the introduction of rotavirus vaccine. Pediatric Infectious Diseases Journal 30(suppl. 1), S16–S20.
17.Quintanar-Solares, M et al. (2011) Impact of rotavirus vaccination on diarrhea-related hospitalizations among children <5 years of age in Mexico. Pediatric Infectious Diseases Journal 30(suppl. 1), S11–S15.
18.de Palma, O et al. (2010) Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. British Medical Journal 340, c2825.
19.Safadi, MA et al. (2010) Hospital-based surveillance to evaluate the impact of rotavirus vaccination in Sao Paulo, Brazil. Pediatric Infectious Diseases Journal 29, 1019–1022.
20.Yen, C et al. (2011) Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatric Infectious Diseases Journal 30(suppl. 1), S6–10.
21.Richardson, V et al. (2010) Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. New England Journal of Medecine 362, 299–305.
22.De Oliveira, LH et al. (2013) Temporal trends in diarrhea-related hospitalizations and deaths in children under age 5 before and after the introduction of the rotavirus vaccine in four Latin American countries. Vaccine 31(suppl. 3), C99–C108.
23.Costa, I et al. (2016) Sustained decrease in gastroenteritis-related deaths and hospitalizations in children less than 5 years of age after the introduction of rotavirus vaccination. A time-trend analysis in Brazil (2001–2010). Pediatric Infectious Diseases Journal 35, e180–e190.
24.Tate, JE et al. (2016) World Health Organization–coordinated global rotavirus surveillance network. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clinical Infectious Diseases 62(suppl. 2), S96–105.
25.Bruijning-Verhagen, P et al. (2013) Targeted rotavirus vaccination of high-risk infants: a low cost and highly cost-effective alternative to universal vaccination. BioMed Central 11, 112.